# THE EFFECT OF ARGININE AND GLUTAMINE ON COVID-19 PATIENTS OUTCOME: A RANDOMIZED CLINICAL TRIAL

> **NCT06004375** · PHASE3 · COMPLETED · sponsor: **Universitas Sriwijaya** · enrollment: 20 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DIETARY_SUPPLEMENT:** Neomune

## Key facts

- **NCT ID:** NCT06004375
- **Lead sponsor:** Universitas Sriwijaya
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-01
- **Primary completion:** 2023-05-30
- **Final completion:** 2023-05-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06004375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06004375, "THE EFFECT OF ARGININE AND GLUTAMINE ON COVID-19 PATIENTS OUTCOME: A RANDOMIZED CLINICAL TRIAL". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06004375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*